CDKN2AMutations in Multiple Primary Melanomas
Jose Gerard Monzon, Ling Liu, Herbert Brill et al. · New England Journal of Medicine · 1998
BACKGROUND: Germ-line mutations in the CDKN2A tumor-suppressor gene (also known as p16, p16INK4a, and MTS1) have been linked to the development of melanoma in some families with inherited melanoma. Whether mutations in CDKN2A confer a predisposition to sporadic (nonfamilial) melanoma is not known. In some patients with sporadic melanoma, one or more additional primary lesions develop, suggesting that some of these patients have an underlying genetic susceptibility to the cancer. We hypothesized that this predisposition might be due to germ-line CDKN2A mutations. METHODS: We used the polymerase chain reaction, single-strand conformation polymorphism analysis, and direct DNA sequencing to identify germ-line mutations in the CDKN2A gene in patients with multiple primary melanomas who did not have family histories of the disease. A quantitative yeast two-hybrid assay was used to evaluate the functional importance of the CDKN2A variants. RESULTS: Of 33 patients with multiple primary melanomas, 5 (15 percent; 95 percent confidence interval, 4 percent to 27 percent) had germ-line CDKN2A mutations. These included a 24-bp insertion at the 5' end of the coding sequence, three missense mutations (Arg24Pro, Met53Ile, and Ser56Ile), and a 2-bp deletion at position 307 to 308 (resulting in a truncated CDKN2A protein). In three families, CDKN2A mutations identical to those in the probands were found in other family members. In two families with mutations, we uncovered previously unknown evidence of family histories of melanoma. CONCLUSIONS: Some patients with multiple primary melanomas but without family histories of the disease have germ-line mutations of the CDKN2A gene. The presence of multiple primary melanomas may signal a genetic susceptibility to melanoma not only in the index patient but also in family members, who may benefit from melanoma-surveillance programs.
Cited by 264 works. doi:10.1056/nejm199803263381305 Open-access PDF
Authors
- Jose Gerard Monzon
- Herbert Brill
- Alisa M. Goldstein
- Margaret Anne Tucker
- Lynn From
- John R McLaughlin
- David Hogg
- Norman J. Lassam
References
- Cancer Cell Cycles
- Germline p16 mutations in familial melanoma
- Second primary neoplasms in patients with retinoblastoma
- Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
- Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
- High Risk of Malignant Melanoma in Melanoma-Prone Families with Dysplastic Nevi
- Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma
- Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome
- Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations
- [16] Analyzing protein-protein interactions using two-hybrid system